GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBF) » Definitions » Cyclically Adjusted Revenue per Share

CLPBF (Coloplast AS) Cyclically Adjusted Revenue per Share : $14.66 (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Coloplast AS's adjusted revenue per share for the three months ended in Sep. 2024 was $4.590. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $14.66 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Coloplast AS's average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Coloplast AS was 10.30% per year. The lowest was 5.60% per year. And the median was 10.00% per year.

As of today (2024-12-14), Coloplast AS's current stock price is $112.54. Coloplast AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was $14.66. Coloplast AS's Cyclically Adjusted PS Ratio of today is 7.68.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Coloplast AS was 16.78. The lowest was 7.55. And the median was 10.72.


Coloplast AS Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Coloplast AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Cyclically Adjusted Revenue per Share Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.98 12.15 11.06 12.89 14.66

Coloplast AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.89 13.96 13.49 13.75 14.66

Competitive Comparison of Coloplast AS's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Coloplast AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Cyclically Adjusted PS Ratio falls into.



Coloplast AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast AS's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=4.59/118.9000*118.9000
=4.590

Current CPI (Sep. 2024) = 118.9000.

Coloplast AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 2.567 99.400 3.071
201503 2.343 100.200 2.780
201506 2.494 100.300 2.956
201509 2.575 100.200 3.056
201512 2.503 99.800 2.982
201603 2.529 100.200 3.001
201606 2.618 100.600 3.094
201609 2.660 100.200 3.156
201612 2.510 100.300 2.975
201703 2.625 101.200 3.084
201706 2.783 101.200 3.270
201709 2.989 101.800 3.491
201712 2.957 101.300 3.471
201803 3.148 101.700 3.680
201806 3.123 102.300 3.630
201809 3.118 102.400 3.620
201812 3.098 102.100 3.608
201903 3.119 102.900 3.604
201906 3.269 102.900 3.777
201909 3.193 102.900 3.689
201912 3.286 102.900 3.797
202003 3.354 103.300 3.861
202006 3.126 103.200 3.602
202009 3.412 103.500 3.920
202012 3.643 103.400 4.189
202103 3.568 104.300 4.067
202106 3.673 105.000 4.159
202109 3.785 105.800 4.254
202112 3.683 106.600 4.108
202203 3.825 109.900 4.138
202206 3.906 113.600 4.088
202209 3.798 116.400 3.880
202212 4.093 115.900 4.199
202303 4.105 117.300 4.161
202306 4.179 116.400 4.269
202309 3.965 117.400 4.016
202312 4.423 116.700 4.506
202403 4.273 118.400 4.291
202406 4.417 118.500 4.432
202409 4.590 118.900 4.590

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Coloplast AS  (OTCPK:CLPBF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Coloplast AS's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=112.54/14.66
=7.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Coloplast AS was 16.78. The lowest was 7.55. And the median was 10.72.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Coloplast AS Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Coloplast A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q4 2020 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S to Acquire Atos Medical Call Transcript

By GuruFocus Research 02-13-2024

Q3 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S's Dividend Analysis

By GuruFocus Research 05-17-2024

Q4 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus News 11-06-2024

Q2 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2022 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024